stockportfolio.pro
Bio-Rad Laboratories, Inc. Total Debt 2008–2025
Bio-Rad Laboratories, Inc. (BIO) annual total debt (short- plus long-term borrowings) by fiscal year, computed from SEC filings.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $1.20B | +0.2% |
| FY 2024 | $1.20B | -0.8% |
| FY 2023 | $1.21B | +1.0% |
| FY 2022 | $1.20B | +11291.5% |
| FY 2021 | $10.51M | -14.2% |
| FY 2020 | $12.26M | -9.7% |
| FY 2019 | $13.58M | -96.9% |
| FY 2018 | $438.94M | — |
| FY 2017 | $0 | — |
| FY 2016 | $0 | — |
| FY 2015 | $0 | — |
| FY 2014 | $0 | -100.0% |
| FY 2013 | $435.80M | -40.5% |
| FY 2012 | $732.60M | +0.0% |
| FY 2011 | $732.30M | -24.1% |
| FY 2010 | $964.20M | +30.7% |
| FY 2009 | $737.92M | — |
| FY 2008 | $0 | — |
Source: Bio-Rad Laboratories, Inc. SEC filings — balance sheet (10-K). Refreshed nightly.
See the full picture for Bio-Rad Laboratories, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeBio-Rad Laboratories, Inc. — frequently asked questions
What is Bio-Rad Laboratories, Inc.'s total debt (short- plus long-term borrowings)?
Bio-Rad Laboratories, Inc. (BIO) reported total debt (short- plus long-term borrowings) of $1.20B for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Bio-Rad Laboratories, Inc.'s official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.